Luo, Xx., Duan, Jg., Liao, Pz. et al. Effect of Qiming Granule (芪明颗粒) on retinal blood circulation of diabetic retinopathy: A multicenter clinical trial., Chin. J. Integr. Med. 15, 384–388 (2009). https://doi.org/10.1007/s11655-009-0384-5
Xiang-xia Luo, Jun-guo Duan, Pin-zheng Liao, et al. Effect of Qiming Granule (芪明颗粒) on retinal blood circulation of diabetic retinopathy: A multicenter clinical trial[J]. Chinese Journal of Integrative Medicine, 2009,15(5):384-388.
Luo, Xx., Duan, Jg., Liao, Pz. et al. Effect of Qiming Granule (芪明颗粒) on retinal blood circulation of diabetic retinopathy: A multicenter clinical trial., Chin. J. Integr. Med. 15, 384–388 (2009). https://doi.org/10.1007/s11655-009-0384-5DOI:
Xiang-xia Luo, Jun-guo Duan, Pin-zheng Liao, et al. Effect of Qiming Granule (芪明颗粒) on retinal blood circulation of diabetic retinopathy: A multicenter clinical trial[J]. Chinese Journal of Integrative Medicine, 2009,15(5):384-388. DOI: 10.1007/s11655-009-0384-5.
Effect of Qiming Granule (芪明颗粒) on retinal blood circulation of diabetic retinopathy: A multicenter clinical trial
摘要
To objectively assess the effect of Qiming Granule (芪明颗粒) in the treatment of diabetic retinopathy (DR) by fluorescence fundus angiography (FFA). In a multi-center
randomized
parallel controlled clinical trial
patients with DR were randomly assigned to the control group (calcium dobesilate capsule) and the test group (Qiming Granule). Changes in the retinal blood circulation time were recorded by FFA after 3 months of medication. Significant reduction was observed in the retinal arterio-venous circulation time (AVCT) in both groups (P<0.01)
the value was 7.635±3.149 s before treatment and 5.165 ±3.382 s after treatment in the treated group
and 7.737±3.413 s and 5.313±3.472 s in the control group respectively. Qiming Granule also reduced the arm-to-retinal circulation time (ARCT
P<0.05). The value was 17.867±3.872 s before treatment and 15.643±4.648 s after treatment in the treated group
and 17.217±3.833 s and 16.312±3.613 s in the control group (P>0.05) respectively. The ARCT in the tested group was reduced
with a statistically significant difference post-medication (P<0.01). As a Chinese medicine complex prescription
Qiming Granule may alleviate retinal hypoxia and ischemia by increasing retinal blood flow and improving the blood circulation.
Abstract
To objectively assess the effect of Qiming Granule (芪明颗粒) in the treatment of diabetic retinopathy (DR) by fluorescence fundus angiography (FFA). In a multi-center
randomized
parallel controlled clinical trial
patients with DR were randomly assigned to the control group (calcium dobesilate capsule) and the test group (Qiming Granule). Changes in the retinal blood circulation time were recorded by FFA after 3 months of medication. Significant reduction was observed in the retinal arterio-venous circulation time (AVCT) in both groups (P<0.01)
the value was 7.635±3.149 s before treatment and 5.165 ±3.382 s after treatment in the treated group
and 7.737±3.413 s and 5.313±3.472 s in the control group respectively. Qiming Granule also reduced the arm-to-retinal circulation time (ARCT
P<0.05). The value was 17.867±3.872 s before treatment and 15.643±4.648 s after treatment in the treated group
and 17.217±3.833 s and 16.312±3.613 s in the control group (P>0.05) respectively. The ARCT in the tested group was reduced
with a statistically significant difference post-medication (P<0.01). As a Chinese medicine complex prescription
Qiming Granule may alleviate retinal hypoxia and ischemia by increasing retinal blood flow and improving the blood circulation.
Duan JG, Liao PZ, Wu L, Li YM, Yu YG, Qiu B, et al. Randomized controlled double-blind multicentric clinical trail on non-proliferative diabetic retinopathy treated by Qiming Granule. J Chengdu Univ Tradit Chin Med (Chin) 2006;29(2):1–5.
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: Department of Noncommunicable Disease Surveillance; 1999.
Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 2003;110:1677–1682.
Zhang CF, Zhang HR. Diabetic eye complications and treatment. 1st ed. Beijing: People’s Medical Publishing House; 2003:8.
She HN, Xu QY. Changes in the blood rheology of patients with diabetic retinopathy. Recent Adv Ophthalmol (Chin) 1999;19:258–259.
Brunet J, Farine JC, Garay RP, Hannaert P. Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat. Eur J Pharmacol 1998;358:213–220.
Leite EB, Mota MC, Abreu JR, Cunha-Vaz JG. Effect of calcium dobesilate on the blood-retinal barrier in early diabetic retinopathy. Int Ophthalmol1990;14:81–88.
Li S, Wang B. Treatment combined with Western and Chinese medicine for diabetic retinopathy in 38 cases. Chin J Pract Ophthalmol (Chin) 2006;24:173.
Huang YF. Treatment combined with Western and Chinese medicine for diabetic retinopathy in 70 cases. Sichuan J Tradit Chin Med (Chin) 2004;22(8);94.
Jin FD. Pharmacological effects of Radix Astragali research and clinical application. J Pract Med Tech (Chin) 2008;15:2702–2704.
Ji ZQ, Gao XX. Experimental study on anti-human platelet aggregation with 63 kinds of regulating lipids Chinese medicine. Shandong J Tradit Chin Med (Chin) 1998;17:365–367.
Zhang M, Zheng HY. Effects of puerarin on erythrocyte deformability in brain infarction patient. J Anhui Tradit Chin Med Coll (Chin) 1996;15(5):12.
Liu AQ, Liao PZ, Zheng YL, Duan JG. Effect of Qiming Granule on antioxidatizing reaction in the retinal tissue of diabetic rats. J Tradit Chin Ophthalmol (Chin) 2003;13(3):128–130.
Stationary Treatment Compared with Individualized Chinese Medicine for Type 2 Diabetes Patients with Microvascular Complications: Study Protocol for a Randomized Controlled Trial
相关作者
暂无数据
相关机构
Guangdong Provincial Hospital of Traditional Chinese medicine
Affiliated Hospital of Liaoning College of Traditional Chinese Medicine
Institute of Medicinal Plant Development, Chinese Academy of Medical Sciences and Peking Union Medical College
Experiment Research Center, Xiyuan Hospital, China Academy of Chinese Medical Sciences
College of Ophthalmology, Chengdu University of Traditional Chinese Medicine